Aβ-amyloid and Tau Imaging in Dementia

Area of Science:

• Neurology
• Neuroimaging
• Alzheimer's Disease Research

Background:

• In vivo imaging of amyloid-beta (Aβ) pathology has revolutionized Alzheimer disease (AD) assessment.
• Aβ imaging provides accurate, reproducible quantification of Aβ burden, aiding clinical trials and patient stratification.

Purpose of the Study:

• To explore the long-term impact of Aβ deposition on cognitive decline.
• To investigate the interplay between Aβ and tau pathology in Alzheimer disease progression.
• To determine the respective roles of Aβ and tau in neurodegeneration and clinical outcomes.

Main Methods:

• Utilizing in vivo Aβ imaging to track Aβ deposition over time.
• Analyzing the correlation between Aβ burden and cognitive impairment in aging and mild cognitive impairment populations.
• Integrating selective tau imaging to differentiate Aβ and tau contributions.

Main Results:

• Aβ accumulation is a protracted process, occurring over two decades prior to clinical symptoms.
• Aβ burden shows a correlation with memory impairment and increased risk of cognitive decline.
• The role of tau pathology in mediating Aβ-related effects requires further investigation.

Conclusions:

• Aβ deposition is a significant factor in Alzheimer disease pathogenesis, contributing to cognitive decline.
• Combining Aβ and tau imaging is crucial for understanding their complex relationship in AD.
• Longitudinal studies are necessary to elucidate the independent and synergistic effects of Aβ and tau on disease progression.